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Abstract
Background. Whether severe obstetric complications (OCs), which harm neural function in
offspring, contribute to impaired cognition found in psychiatric disorders is currently
unknown. Here, we sought to evaluate how a history of severe OCs is associated with cognitive
functioning, indicated by Intelligence Quotient (IQ).
Methods. We evaluated the associations of a history of OCs and IQ in 622 healthy controls
(HC) and 870 patients on the schizophrenia (SCZ) – bipolar disorder (BIP) spectrum from
the ongoing Thematically Organized Psychosis study cohort, Oslo, Norway. Participants
underwent assessments using the NART (premorbid IQ) and the WASI (current IQ).
Information about OCs was obtained from the Medical Birth Registry of Norway. Multiple
linear regression models were used for analysis.
Results. Severe OCs were equally common across groups. SCZ patients with OCs had lower
performances on both premorbid and current IQ measures, compared to those without OCs.
However, having experienced more than one co-occurring severe OC was associated with
lower current IQ in all groups.
Conclusions. Severe OCs were associated with lower IQ in the SCZ group and in the BIP and
HC groups, but only if they had experienced more than one severe OC. Low IQ might be a
neurodevelopmental marker for SCZ; wherein, severe OCs influence cognitive abilities and
increase the risk of developing SCZ. Considering OCs as a variable of neurodevelopmental
risk for severe mental illness may promote the development of neuroprotective interventions,
improve outcome in vulnerable newborns and advance our ability to make clinical prognoses.
Introduction
Exposure to a broad category of adversities during the fetal period or delivery, herein called
obstetric complications (OCs), increases schizophrenia risk 1.5–5 fold (Cannon et al.,
2002b; Geddes and Lawrie, 1995; Nosarti et al., 2012; Pugliese et al., 2019). Recent findings
on the interaction of genetic and OCs risk factors have linked neural insult to schizophrenia
(Ursini et al., 2018). The liability towards schizophrenia explained by genetic risk predicted the
diagnosis in the presence of OCs, but not in their absence (Ursini et al., 2018). The influence
of OCs in the risk for developing bipolar disorders is less clear (Nosarti et al., 2012; Pugliese
et al., 2019; Scott et al., 2006).
Impaired cognition is common in psychiatric disorders (Van Rheenen et al., 2017), yet the
degree of neurodevelopmental abnormalities is greater in schizophrenia than bipolar disorder
(Demjaha et al., 2012), i.e. excessive neuromotor delays and cognitive difficulties were found in
children who later developed schizophrenia compared to those who later developed affective
disorders (Cannon et al., 2002a). Neuromotor abnormalities relate consistently to intelligence
quotient (IQ) abilities and remain central in adult schizophrenia (Vaskinn et al., 2014). Even
though schizophrenia and bipolar disorder are nosologically distinct, studies have revealed
shared cognitive heterogeneity (Bora and Pantelis, 2015; Hill et al., 2013; Tamminga et al.,
2014; Van Rheenen et al., 2016; Van Rheenen et al., 2017).
Certain features of cognition appear to be unaffected by disease processes (e.g. schizophre-
nia, dementia, depression), and cognitive measures such as word-reading ability can act as
‘hold tests’ to estimate premorbid IQ (Nelson and Willison, 1991). Other aspects of cognition
seem to deteriorate with the course of illness; tests of more fluid intelligence provide an indi-
cation of current cognitive abilities in patients. In fact, lower premorbid IQ was related to more
severe cognitive impairment across schizophrenia and bipolar diagnoses with larger deficits
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observed in schizophrenia (Van Rheenen et al., 2017). Premorbid
IQ was highly predictive of psychotic disorders in an umbrella
review (Khandaker et al., 2011; Radua et al., 2018; Woodberry
et al., 2008), confirming the role of a cognitive antecedent in
psychosis onset.
To date, little is known about the effects of having experienced
OCs on cognition in severe mental illness. The most recent study
of OCs’ association to cognitive functioning was a clinical cohort
study of 157 patients in the year 2000 and showed no relationship
within patients with affective psychosis and schizophrenia
(Gilvarry et al., 2000). They did, however, find differences in pre-
morbid IQ between patients and their first-degree relatives, where
the greatest IQ disparity was found between patients with OCs
and their relatives. The larger deficit in patients with OCs could
not be explained by shared genetic factors alone and is an indica-
tion that OCs might contribute to the lower premorbid IQ in
these patients.
The evolving inference is that the intra-uterine environment
partly mediates the genomic risk of schizophrenia, which has
basic implications for pathogenesis (Birnbaum and Weinberger,
2017; Ursini et al., 2018). Investigating the pre- and perinatal per-
iod can be challenging, as data are usually collected retrospect-
ively. Small sample sizes, lack of statistical power to measure
small-interactive effects and inefficient reporting on the pre-
and perinatal period have restricted knowledge on the contribu-
tion of OCs in mental illness (Cannon et al., 2002b; Radua
et al., 2018).
To overcome these limitations, we utilized the Medical Birth
Registry of Norway (MBRN) to provide unique insight into preg-
nancy and birth information on 1492 patients and healthy con-
trols in the Thematically Organized Psychosis (TOP) study
cohort. The main goal of this study was to investigate putative
effects of a history of OCs on adult cognition in schizophrenia
and bipolar spectrum disorders. Neurodevelopmental implica-
tions of severe OCs might be marked cognitive impairments pre-
sent before and after disease onset. A more severe disease
progression indicated by a cognitive decline that reflects both
early cognitive deficits and more severe course of pathology
from the time of illness onset (Wells et al., 2015; Van Rheenen
et al., 2017). Our study objectives in the clinical cohort of patients
on the schizophrenia-bipolar spectrum and healthy controls
aimed to: (1) investigate the prevalence of severe OCs across diag-
noses through information obtained in the MBRN; (2) examine
premorbid and current IQ of OCs-defined subgroups; (3) deter-
mine differential effects of OCs by diagnostic category; (4) assess
the effects of the number of co-occurring OCs and (5) examine
the degree to which OCs-defined subgroups could be differen-
tiated on demographic and clinical measures.
Materials and methods
Participants
The TOP study is a thematic study research effort focused on the
disease mechanisms of psychotic disorders and is the main study
protocol at the Norwegian Centre for Mental Disorders Research
(NORMENT, Oslo, Norway; www.med.uio.no/norment/english).
Adult patients were recruited consecutively from psychiatric
units (outpatient and inpatient) of public hospitals in the Oslo
region, which have the complete catchment-based service area
covering about one million inhabitants of Oslo’s urban area.
The hospitals are located in different parts of the city and are
representative of the city’s variation in sociodemographic charac-
teristics. The healthy controls (HC) were randomly selected from
the national population register and were residents in the same
catchment area as the patients. After a complete description of
the study, all participants gave written informed consent. The
Regional Committee for Research Ethics and the Norwegian
Data Inspectorate approved the study.
Exclusion criteria for both patients and HC were hospitaliza-
tion for previous moderate or severe head injury, neurological dis-
order, medical conditions thought to interfere with brain function
and age outside the range of 18–65 years. Additional exclusion
criteria for HC were current or previous somatic illness and sub-
stance misuse disorders or dependency within the last 6 months.
HC were also excluded if they or a first-degree relative had a life-
time history of severe psychiatric disorder.
All patients underwent thorough clinical investigation by
trained psychologists and physicians. Clinical diagnoses were
assessed using the Structured Clinical Interview for DSM-IV
axis 1 disorder (SCID-I) module A-E (Spitzer et al., 1988).
Psychosocial function was assessed with the Global Assessment
of Function scale, split version (GAF; Pedersen et al., 2007).
Current psychotic symptoms were rated by the use of the
Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987).
HC were interviewed by trained research assistants and exam-
ined with the Primary Care Evaluation of Mental Disorders
(Prime-MD) to ensure no current or previous psychiatric disor-
ders (Spitzer et al., 1994).
From the onset of the study in October 2002 until June 2015,
the total subject sample (n = 1492) consisted of patients with a
DSM-IV diagnosis within the schizophrenia spectrum (SCZ):
schizophrenia (DSM-IV 295.1, 295.3, 295.6, and 295.9; n = 346),
schizophreniform disorder (DSM-IV 295.4; n = 43), schizoaffect-
ive disorder (DSM-IV 295.7; n = 70) or psychosis not otherwise
specified (DSM-IV 298.9; n = 148); or within the bipolar spectrum
(BIP): Bipolar I disorder (DSM-IV 296.0–7; n = 164), Bipolar II
disorder (DSM-IV 296.89; n = 80) or bipolar disorder not other-
wise specified (DSM-IV 296.80; n = 19); and HC (n = 622).
Obstetric complications
Birth data were collected from the national MBRN. In Norway,
there is mandatory reporting on all births after gestational week
16 (online Supplementary material – Appendix 1: MBRN form
from 1967–1998). MBRN data were scored for the presence and
severity of OCs (McNeil and Sjöström, 1995) by two physicians
(UKH and KE) who were blinded to patient/ control status (inter-
rater reliability = 0.94).
The validated McNeil–Sjöström scale (McNeil et al., 1994;
McNeil and Sjöström, 1995) includes several hundred events of
potential harm to the fetus/offspring, each classified according
to severity on an ordinal scale from 1 to 6. As in other reports
(Nicodemus et al., 2008; Haukvik et al., 2014), an incidence of
severe OCs was reported in those participants who had experi-
enced one or more complications of a grade 5 or 6. Subjects
with complications of grade 4 and below were classified as having
an absence of severe OCs. A complication of grade 5 is defined as
an event that is ‘potentially clearly greatly relevant/harmful’ to the
central nervous system of the developing fetus/offspring, and a
complication of grade 6 is defined as an event that causes ‘very
great harm to or deviation in offspring’ (McNeil and Sjöström,
1995). Examples of grade 5 or 6 are as follows: severe preeclamp-
sia, bleeding before 28 weeks, asphyxia, discolored placenta/
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amniotic fluid, emergency caesarean delivery, preterm birth ⩽35
weeks, low Apgar score (0–3 at 1 min or 0–7 at 5 min), bleeding
during labor, low birth weight ⩽2000 g and eclampsia (see online
Supplementary material – Note: Obstetric complications for more
details).
IQ measures
Current IQ was evaluated using the Wechsler Abbreviated Scale of
Intelligence (WASI) full scale IQ assessment (Wechsler, 2007).
The National Adult Reading Test (NART) was designed to give
an indication of cognitive functioning preceding symptoms of dis-
ease and word-reading skills are significantly correlated with
Wechsler-based IQ scores (Nelson and Willison, 1991). The reli-
ability and validity of the Norwegian language version of the
NART have been established (Sundet and Vaskinn, 2008). The
premorbid IQ estimate was calculated using the WASI full scale
IQ formula (Sundet and Vaskinn, 2008). Cognitive decline was
calculated by subtracting premorbid IQ from current IQ scores
(current IQ – premorbid IQ) and will be referred to as IQ differ-
ence scores.
Statistical analyses
Statistical analyses were performed within the Statistical Package
of Social Sciences (SPSS), version 25 (IBM, USA; www.spss.com).
Demographic and clinical characteristics were compared
between groups using chi-squared tests for categorical variables
and analysis of variance (ANOVA) or covariance (ANCOVA)
for continuous variables. Age, years of education and sex distribu-
tions were identified as potential confounders on cognitive vari-
ables, and we adjusted accordingly in between-group analyses.
Subjects with missing data on any particular variable were omit-
ted from analyses involving that variable, but were included in
analyses for which all required variables were present.
Three separate multiple linear regressions were calculated for
premorbid IQ, current IQ or IQ difference scores (as dependent
variables), respectively. Age, education, sex, OCs, HC v. BIP,
HC v. SCZ, OC*BIP and OC*SCZ were entered as independent
variables. Premorbid IQ was estimated from NART total errors,
and covariates (age, education and sex) were adjusted for in the
regression models.
To assess differences in the number of OCs frequency between
groups, we preformed chi-squared tests. Further, to examine if
cognitive abilities were directly related to the number of
co-occurring OCs that were rated 5 and 6 in each group, we per-
formed two additional multiple regression analysis entering IQ
variables as dependent variables and age, education level, sex,
HC v. SCZ, HC v. BIP, One OC, Two or more (2+) OCs as inde-
pendent variables. In the second regression, age, education level,
sex, One OC, Two OCs and Three or more (3+) OCs were com-
pared in only HC v. SCZ because the BIP group had too few cases
of 3 or more OCs.
Results
Demographic and clinical variables
There were significant differences in sex distribution and educa-
tion levels between the three participant groups (Table 1). Age
did not differ between patient groups, but it did differ between
patient groups and HC. Between the patient groups, age at illness
onset, illness duration, PANSS scores and GAF scores were sig-
nificantly different. In the BIP group, age of illness onset was earl-
ier than in the SCZ group. The duration of illness was longer in
the BIP group than in the SCZ group. A greater degree of clinical
symptoms was found in the SCZ group compared to the BIP
group and functioning was significantly reduced in the SCZ
group, as well. Age at illness onset, illness duration, PANSS and
GAF variables did not differ as a function of OCs within patient
groups. Current IQ and IQ difference scores differed between
groups. Negative IQ difference scores indicated a discrepancy
between current IQ and premorbid IQ. Premorbid IQ estimates
did not differ between the BIP group and HC, but differed
between the SCZ group and HC. Across all three groups, there
were no significant differences in birth weight or gestational age.
Obstetric complications
There were no significant differences in the frequency of OCs
between groups (Table 2). However, two of the complications
(preterm and low birth weight) were more frequent in the
group with SCZ patients, compared to the HC. Bleeding during
labor occurred more often in the HC in comparison to the SCZ
group. The most frequent OCs across groups were asphyxia
(⩾50%) and discolored placenta/amniotic fluid (⩾39%).
IQ measures
Multiple linear regression analyses revealed that the independent
variables predicted premorbid IQ, current IQ and IQ difference
scores in the overall models (Table 3). Each model explained
24%, 31% and 23% of the variance in the change of IQ scores,
respectively. We found an OCs by SCZ group interaction on pre-
morbid and current IQ variables. An interaction effect indicated
that within the SCZ group, patients with a history of OCs had
lower premorbid and current IQ compared to SCZ patients with-
out a history of OCs. This was not the case for the HC or BIP
groups.
Because OCs are not isolated events and commonly occur
together (McNeil and Sjöström, 1995), we assessed the number
of OCs that were rated 5 and 6 in each group using chi-squared
analyses. We found no statistically significant differences
(χ2 (2) = 1.63, p = 0.442) in the number of co-occurring OCs (1
and 2+) between the SCZ group (1 OC = 56%; 2 + OCs = 44%),
the BIP group (1 OC = 61%; 2 + OCs = 39%) and HC (1 OC =
63%; 2 + OCs = 37%). In the BIP group, there were only 3 cases
with 3 + OCs, so the BIP group was not included in these ana-
lyses. We found no statistically significant differences (χ2 (2) =
4.87, p = 0.088) in the number of co-occurring OCs (1, 2 and 3
+) between the SCZ group (1 OC = 56%; 2 OCs = 31%; 3 + OCs
= 13%) and HC (1 OC = 63%; 2 OCs = 31%; 3 + OCs = 6%).
Furthermore, we found premorbid IQ scores were significantly
lower with more than 2 severe OCs in both adult patients with
SCZ and HC (online Supplemental materials: Table S1B and
Fig. 1a). This was not the case for BIP group, as they did not differ
from the HC on premorbid IQ measures. Current IQ measures
were significantly lower if more than one severe OC was experi-
enced, and this effect was observed in all groups (online
Supplemental materials: Table S1A and Fig. 1b). IQ difference
scores (current IQ – premorbid IQ) showed a significant decrease
in IQ scores in those that had experienced more than one severe
OC, also seen in all groups (online Supplemental materials:
Table S1A and Fig. 1c). In those with 2 + OCs, asphyxia-related
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Table 1. Demographic and clinical characteristics
HC BIP SCZ HC v. BIP HC v. SCZ BIP v. SCZ
N = 622 N = 263 N = 607 χ2/t p χ2/t p χ2/t p
Sex (% female) 0.46 0.63 0.39 19.98 0.000 6.92 0.009 42.04 0.000
Mean S.D. Mean S.D. Mean S.D.
Age (years) 30.06 6.91 27.56 6.34 27.04 6.50 −5.12 0.000 −7.96 0.000 −1.10 0.278
Education (years) 14.32 2.25 13.27 2.26 12.17 2.35 −6.00 0.000 −15.85 0.000 −6.10 0.000
Birth weight (grams)a 3521 538 3556 558 3481 576 1.40 0.162 −1.57 0.117 −2.38 0.018
Gestation age (weeks) 39.91 1.78 39.88 1.93 39.61 2.49 −0.14 0.887 −2.42 0.016 −1.57 0.117
Age at illness onset 19.03 5.99 21.89 6.17 6.28 0.000
Illness duration (years) 8.58 6.45 5.21 5.35 −7.92 0.000
PANSS 45.98 10.06 62.45 16.62 14.71 0.000
General 25.66 5.80 32.04 8.40 11.07 0.000
Negative 10.33 3.64 15.41 6.24 12.15 0.000
Positive 10.06 3.65 14.94 5.16 13.73 0.000
GAF-S 56.86 11.37 42.92 11.89 −15.96 0.000
GAF-F 55.19 12.95 44.58 12.21 −11.47 0.000
Premorbid IQb 112.99 1.72 112.22 1.71 110.04 1.75 0.48 0.631 −4.79 0.000 −3.61 0.000
Current full scale IQc 113.30 5.16 108.74 4.89 100.79 5.26 −2.19 0.028 −10.33 0.000 −5.32 0.000
IQ difference scored 0.34 3.64 −3.45 3.39 −8.45 3.72 −2.81 0.005 −9.19 0.000 −4.20 0.000
aAdjusted for sex; S.D. (standard deviation); HC (healthy controls); BIP (bipolar spectrum); SCZ (schizophrenia spectrum); PANSS (Positive and Negative Syndrome Scale); GAF-S (Global Assessment of Functioning- symptoms); GAF-F (Global Assessment
of Functioning-functioning). Bold numbers represent significant values.
bNART premorbid IQ estimate adjusted for age, education and sex (HC: N = 582, BIP: N = 230 and SCZ: N = 411).
cWASI full scale IQ assessment adjusted for age, education and sex (HC: N = 580, BIP: N = 235 and SCZ: N = 428).
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OCs were identified in 88% (50 out of 57) of the healthy controls,
81% (21 out of 26) of patients in the bipolar group and 71% (29
out of the 41) of patients in the schizophrenia group. We identi-
fied 15 schizophrenia patients with current IQ below 70 in our
sample, and 33% (5 out of 15) had severe OCs in their histories.
Discussion
We found severe OCs to be equally common across groups, and
the number of OCs co-occurring was also similar. An interaction
effect indicated that within the schizophrenia group, patients with
a history of OCs had lower premorbid and current IQ compared
to schizophrenia patients without a history of OCs. To have
experienced more than two co-occurring OCs was specifically
associated with lower premorbid IQ in both patients within the
schizophrenia group and healthy controls, but not in the bipolar
group. However, more than one co-occurring OC was related to
lower current IQ and greater decreases in IQ difference scores
in all participant groups.
Despite scientific reports that have stressed the role of OCs as a
risk factor for the development of schizophrenia (Cannon et al.,
2002b; Geddes and Lawrie, 1995; Nosarti et al., 2012; Pugliese
et al., 2019), the precise nature of their relationship to cognitive
functioning in psychiatric disorders is unknown. We report that
severe OCs occurred in 28% of patients within the schizophrenia
group, but we also observed similar numbers in both the bipolar
patient group and healthy control group, which is comparable to
what has been reported in other studies (Haukvik et al., 2009;
Nicodemus et al., 2008; Ursini et al., 2018). These findings sup-
port the idea that having a history of OCs might be an addi-
tive/interactive risk for the development of a psychiatric
disorder (Walter and Holford, 1978). Since OCs were equally
occurring in all groups, psychiatric disorders must be mainly
determined by other factors and not directly caused by OCs.
Severe OCs might be an additional factor, wherein their presence
further increases the probability of developing a condition with a
more severe cognitive course. In this study, we found that the
associations between OCs and IQ were stronger in patients within
the schizophrenia group, compared to the bipolar group, but were
also observed in the healthy controls.
IQ is the most discriminating neuropsychological variable
between patients with schizophrenia and affective disorders
(Goldberg et al., 1993). We found that patients with schizophre-
nia and OCs had lower premorbid and current IQ than patients
who had not experienced OCs. Severe OCs in this patient group
can be presumed to have early neurodevelopmental consequences
on cognition, as reduced IQ was present before illness onset.
Common genetic variants associated with schizophrenia are
enriched for associations with lower intelligence (Smeland et al.,
2019) and intracranial volume (Smeland et al., 2018), a proposed
biomarker of brain development (Woodward and Heckers, 2015).
Lower IQ performance might indicate brain alterations and differ-
ing developmental trajectories within schizophrenia. Even though
we did not identify differences on clinical measures between
OCs-related subgroups, more studies are need to clarify the rela-
tionship between OCs, genetic risk, brain changes and clinical
characteristics.
We found that having more than one severe OC, which is
clearly harmful to the developing central nervous system of the
fetus/offspring (McNeil and Sjöström, 1995), was specifically
associated to lower current IQ and greater IQ difference scores
(current IQ – premorbid IQ) in both patient groups and healthy
controls, which indicates a decline in cognition. The significant
discrepancies between current and premorbid IQ in both patient
groups might imply that common pathogenic processes operate
once illness has begun. Additionally, processes may have started
earlier in schizophrenia, as IQ did not differ between the bipolar
group and healthy controls, premorbidly, which gives an indica-
tion that there might be better resilience in bipolar disorder.
Yet, lower current IQ and greater IQ difference scores in those
who had experienced more than one OC might suggest a more
vulnerable neurodevelopmental subgroup of both patient groups
and healthy controls who are less resilient to age-related processes
or pathological processes beginning later in life.
We found that 50% of all severe OCs were related to asphyxia
at birth (i.e. deprivation of oxygen). Of the participants with more
Table 2. Frequency of obstetric complications
HC BIP SCZ HC v. BIP HC v. SCZ BIP v. SCZ
N = 622 N = 263 N = 607
χ2 p χ2 p χ2 p
N % N % N %
Obstetric complications 166 0.27 85 0.32 170 0.28 2.89 0.089 0.27 0.604 1.65 0.199
Asphyxia 83 0.50 45 0.53 87 0.51 0.20 0.659 0.05 0.829 0.07 0.790
Discolored placenta/amniotic
fluid
71 0.43 37 0.44 67 0.39 0.01 0.909 0.39 0.531 0.40 0.528
Emergency C-section 10 0.06 4 0.05 14 0.08 0.19 0.667 0.62 0.431 1.08 0.300
Preterm ⩽35 weeks 13 0.08 8 0.09 28 0.16 0.18 0.669 5.85 0.016 2.33 0.127
Low Apgar score 5 0.03 3 0.04 12 0.07 0.05 0.825 2.86 0.091 1.28 0.259
Bleeding during labor 33 0.20 12 0.14 19 0.11 1.27 0.260 4.86 0.027 0.46 0.498
Bleeding before 28 weeks 8 0.05 3 0.04 16 0.09 0.22 0.637 2.67 0.102 2.84 0.092
Low birth weight ⩽2000 g 4 0.02 4 0.05 15 0.09 0.96 0.327 6.48 0.011 1.39 0.238
Other birth complications 11 0.07 7 0.08 21 0.12 0.22 0.640 3.20 0.074 0.98 0.321
HC, healthy controls; BIP, bipolar spectrum; SCZ, schizophrenia spectrum. Bold numbers represent significant values.
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than one OC, we identified asphyxia-related OCs in 88% of
healthy controls, 81% of patients in the bipolar group and in
71% of patients in the schizophrenia group. We observed a pat-
tern of lower IQ as the number of OCs increased that might
reflect the magnitude of neurodevelopmental insult of OCs on
cognitive brain development. Asphyxia might specifically impact
the developing brain. It appears that both a greater number of
harmful OCs and asphyxia experienced at birth influence adult
IQ, more so in vulnerable individuals who later develop a severe
mental illness, but a series of OCs do not necessarily lead to a dis-
order. A direction for future research might be to improve knowl-
edge of neural injury due to OCs and implement neuroprotective
interventions for better outcome in vulnerable newborns.
Current pharmacological treatment for schizophrenia mainly
improves positive symptoms, but has no documented improve-
ment on cognitive impairments, which together with negative
symptoms are the most disabling features of schizophrenia long-
term (Fusar-Poli et al., 2015). We identified 15 schizophrenia
Table 3. Multiple regression analyses by premorbid IQ, current IQ and IQ difference scores
Level of IQ performance B β t p F df p adj. R2
Premorbid IQa
Overall model 48.66 8, 1222 0.000 0.24
(Constant) 101.34 129.26 0.000
Age 0.71 0.109 3.88 0.000
Education level 0.65 0.361 12.29 0.000
Sex 0.24 0.027 1.07 0.284
Severe OCs 0.21 0.021 0.58 0.561
HC v. BIP 0.32 0.028 0.85 0.395
HC v. SCZ −0.97 −0.103 −3.13 0.002
OC*BIP −0.57 −0.030 −0.86 0.391
OC*SCZ −1.36 −0.084 −2.36 0.018
Current IQb
Overall model 71.83 8, 1242 0.000 0.31
(Constant) 82.63 36.67 0.000
Age −0.13 −0.065 −2.44 0.015
Education level 2.28 0.418 15.00 0.000
Sex 3.19 0.118 4.94 0.000
Severe OCs 0.27 0.009 0.26 0.796
HC v. BIP −1.50 −0.043 −1.41 0.160
HC v. SCZ −7.17 −0.252 −8.04 0.000
OC*BIP −1.52 −0.027 −0.80 0.422
OC*SCZ −3.73 −0.078 −2.28 0.023
IQ difference scorec
Overall model 46.67 8, 1202 0.000 0.23
(Constant) −17.92 −9.23 0.000
Age −0.21 −0.128 −4.52 0.000
Education level 1.59 0.359 12.07 0.000
Sex 3.06 0.140 5.46 0.000
Severe OCs 0.12 0.005 0.13 0.893
HC v. BIP −1.86 −0.067 −2.03 0.042
HC v. SCZ −5.69 −0.244 −7.36 0.000
OC*BIP −1.00 −0.022 −0.61 0.540
OC*SCZ −2.34 −0.058 −1.63 0.104
HC, healthy controls; BIP, bipolar spectrum; SCZ, schizophrenia spectrum; df, degrees of freedom. Bold numbers represent significant values.
aNART premorbid IQ estimate adjusted for age, education and sex (HC: N = 582, BIP: N = 230 and SCZ: N = 411).
bWASI full scale IQ assessment adjusted for age, education and sex (HC: N = 580, BIP: N = 235 and SCZ: N = 428).
cIQ difference score (current IQ – premorbid IQ) adjusted for age, education and sex (HC: N = 579, BIP: N = 228 and SCZ: N = 396).
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patients with current IQ below 70 in our sample. Excluding this
group from analyses did not alter group proportions, means or
results, and doing so, would not reflect the number of patients
with compromised intellectual function in the schizophrenia
population (Wells et al., 2015). Severe OCs were found in 33%
of these patients, which might have been an additive risk factor
for schizophrenia. We realize that there are other non-purely gen-
etic risk factors, defined as socio-demographic, parental, later fac-
tors and antecedents (Radua et al., 2018), that may increase the
risk or decrease any protective effects and influence the likelihood
of developing a psychiatric disorder. Urbanization, migration,
childhood social withdrawal, childhood trauma, Toxoplasma gon-
dii Immunoglobulin G, and non-right handedness might interact
or be additive risks (Radua et al., 2018) to a genetic predisposition
that operates by impairing the resilience of the fetal and neonatal
brain (Murray et al., 2017). The neurodevelopmental significance
of having experienced severe OCs is that cognitive deficits are
major aspects of treatment-resistant schizophrenia. Therefore,
we need to explore other avenues of treatment and optimize peri-
natal care in vulnerable individuals, for instance in mothers with a
family history of severe psychosis.
Strengths of this study were the use of the Medical Birth
Registry of Norway data, which allows for a more accurate and
prospective assessment of OCs in severe mental illness. Our
study provides a priori knowledge about the pre- and perinatal
environment (indicated with OCs) in patients who later develop
psychiatric disorders. We observed normal-ranged IQ means
(i.e. ≈100) across groups, yet we were still able to identify adverse
effects of OCs on IQ measures. Importantly, it reveals clinical evi-
dence on early life factors and their possible impact on cognition
in adult patients, which is currently missing in the field (Radua
et al., 2018). Including OCs as a component of risk may advance
our ability to make prognoses in psychiatric disorders, which
might soon compliment genetic vulnerability or other predictors.
The use of the NART as an index of prior intellectual ability
(rather than current) is well established with high retrospective
validity. In fact, a 66-year follow up study in healthy individuals
found that NART performance at age 77 and IQ at age 11 had
a highly significant correlation (r = 0.73, p < 0.001) (Crawford
et al., 2001). The validation for the Norwegian version of the
NART for patients with schizophrenia and bipolar disorders
also revealed highly significant correlations between estimated
and actual IQ (r = 0.64, p < 0.001; r = 0.49, p < 0.001, respectively)
(Sundet and Vaskinn, 2008). The use of the NART as an estimate
of premorbid intellectual ability in clinical populations is sup-
ported by this series of results and is in line with the findings
of the present study.
This study has some limitations. Exclusion criteria in the TOP
study precluded recruitment of healthy controls if they had a first-
degree relative with a lifetime history of severe psychiatric dis-
order. Further, despite a random selection from the population,
it seems that the controls were performing above average on cog-
nitive tests. A recent study indicates that large proportions of the
genomic risk underlying schizophrenia also influence intelligence
(Smeland et al., 2019). It is possible that even more pronounced
effect of OCs on IQ would have been evident had more genetically
varied controls been included in the analyses.
Although the NART is a validated measure of premorbid IQ
(Sundet and Vaskinn, 2008), an actual IQ assessment adminis-
tered before the onset of symptoms may more accurately describe
participants, especially in cases of extreme scores (Mathias et al.,
2007).
Even though we did not find an association between OCs and
premorbid IQ in the bipolar group, this group had half the sample
size of the other two groups in our study. Since each type of OC
event is infrequent in a population, the smaller sample size in this
group might lack the statistical power to measure small and inter-
active effects. Cognitive decline, indicated by IQ difference scores,
in the bipolar patients with OCs was significantly lower when the
number of co-occurring OCs was taken into account.
In conclusion, the relevance of this study is that a history of
severe OCs seems to be associated with cognitive functioning in
adult participants. These findings add to new reports indicating
Fig. 1. IQ across the number of co-occurring severe OCs. HC, healthy controls; BIP,
bipolar spectrum; SCZ, schizophrenia spectrum. (a) †NART premorbid IQ estimate;
(b) ¥WASI full scale assessment; and (c) §IQ difference score (current IQ – premorbid
IQ). The numbers below the x-axis refer to the number of co-occurring OCs in partici-
pant histories. Error bars represent ±2 standard errors.
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that genetic risk for schizophrenia is found to start in the womb,
interacting with placental integrity (Ursini et al., 2018). Even
though the placenta might be a key environmental factor for psy-
chopathology, placenta status is also of major importance for IQ
(Jacobs et al., 2001; Patterson, 2007). Low IQ might be a marker
for schizophrenia development and an experience of OCs appears
to increase the risk. A better understanding of early pre- or peri-
natal factors such as OCs and genetic risk in the context of brain
development could advance the role of perinatal care for reducing
the burden of severe mental illness. Also, it may improve strat-
egies for primary prevention of schizophrenia.
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be found at https://doi.org/10.1017/S0033291719002046
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